Annual General Meeting 2020

Presentation

 Company Update

Resolutions 1 to 7 were passed on a poll, including Resolution 7 which was passed as a special resolution.
Annual General Meeting Outline
1. Remuneration Report
2. Re-election of Director - Dr Neale Fong
3. Approval of Employee Securities Incentive Plan
4. Approval of potential termination benefits under the Plan
5 (a). Approval to issue Director Share Rights under the Plan to Mr Michael Lynch Bell (or his nominees)
5 (b). Approval to issue Director Share Rights under the Plan to Dr Neale Fong (or his nominees)
5 (c). Approval to issue Director Share Rights under the Plan to Ms Fleta Solomon (or her nominees)
5 (d). Approval to issue Director Share Rights under the Plan to Mr Angus Caithness (or his nominees)
6 (a). Approval to issue Retention Share Rights under the Plan to Mr Michael Lynch Bell (or his nominees)
6 (b). Approval to issue Retention Share Rights under the Plan to Dr Neale Fong (or his nominees)
7. Approval of 10% Placement Facility
Annual Report

Quick Links

Contact Us

Head Office:
PO Box 101, Wembley,
Perth WA 6913
Ph: +61 8 6280 0050
info@littlegreenpharma.com

Follow Us

Copyright © Little Green Pharma
Site Map Privacy Search
Site by

Email Alerts

Get the latest company news